Understanding FDA Regulation of DTC Genetic Tests within the Context of Administrative Law
- 1 October 2010
- journal article
- editorial
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 87 (4) , 451-456
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Preparing for a Consumer-Driven Genomic AgeNew England Journal of Medicine, 2010
- Risks of Presymptomatic Direct-to-Consumer Genetic TestingNew England Journal of Medicine, 2010
- Which way for genetic-test regulation? Assign regulation appropriate to the level of riskNature, 2010
- Which way for genetic-test regulation? Leave test interpretation to specialistsNature, 2010
- Left to Their Own Devices: Breakdowns in United States Medical Device Premarket ReviewPLOS Medicine, 2010
- The Illusive Gold Standard in Genetic Ancestry TestingScience, 2009
- Direct-to-Consumer Personal Genome Testing: The Problem Is Not Ignorance–It Is Market FailureThe American Journal of Bioethics, 2009
- The regulation of direct-to-consumer genetic testsHuman Molecular Genetics, 2008
- The Current Landscape for Direct-to-Consumer Genetic Testing: Legal, Ethical, and Policy IssuesAnnual Review of Genomics and Human Genetics, 2008
- In search of a coherent framework: options for FDA oversight of genetic tests.2007